3.94 USD
▲+0.01+1.81%
盘后 3.88 +0.13%
2026-08-03
市值
$275.06M
市盈率
—
EPS
-2.74
股息率
—
52 周区间
3.75 – 9.16
成交量
179.65K
Beta
1.55
目标价
9.86
52W 低 3.7552W 高 9.16
价格走势
公司简介
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company’s products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle tumor-targeted imm...